Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haddon

Showing results (491-500 of 509) with videos related to

Pageof 51
Sort By:
Journal of Gastroenterology and Hepatology|April 22, 2023
Idiopathic myointimal hyperplasia of the mesenteric veins: A systematic review and individual patient data regression analysisRaquel Rozner, Savanah Gisriel, John Damianos, et al.
Nature Medicine|November 9, 2021
Fenebrutinib in H<sub>1</sub> antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trialMartin Metz, Gordon Sussman, Rémi Gagnon, et al.
Heliyon|January 14, 2022
DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative TrialJudith C Hugh, Lacey S J Haddon, John Maringa Githaka, et al.
BJUI Compass|April 7, 2023
PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancerVictoria K Woodcock, Ji-Li Chen, Karin Purshouse, et al.
Science (New York, N.Y.)|June 10, 1994
New phases of c60 synthesized at high pressureY Iwasa, T Arima, R M Fleming, et al.
Schizophrenia Bulletin|October 11, 2018
Genetic Variation in the Psychiatric Risk Gene CACNA1C Modulates Reversal Learning Across SpeciesLucy Sykes, Josephine Haddon, Thomas M Lancaster, et al.
Nature Communications|August 3, 2019
Cyfip1 haploinsufficient rats show white matter changes, myelin thinning, abnormal oligodendrocytes and behavioural inflexibilityAna I Silva, Josephine E Haddon, Yasir Ahmed Syed, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 14, 2014
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritisAndrew J Kinloch, Anthony Chang, Kichul Ko, et al.
Atherosclerosis|May 28, 2017
Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemiaMahtab Sharifi, Elizabeth Higginson, Sven Bos, et al.
Experimental Hematology|January 4, 2011
A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosisMichael R Hughes, Nicole Anderson, Steven Maltby, et al.
Pageof 51

Showing results (491-500 of 509) with videos related to

Sort By:
Pageof 51
Journal of Gastroenterology and Hepatology|April 22, 2023
Idiopathic myointimal hyperplasia of the mesenteric veins: A systematic review and individual patient data regression analysisRaquel Rozner, Savanah Gisriel, John Damianos, et al.
Nature Medicine|November 9, 2021
Fenebrutinib in H<sub>1</sub> antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trialMartin Metz, Gordon Sussman, Rémi Gagnon, et al.
Heliyon|January 14, 2022
DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative TrialJudith C Hugh, Lacey S J Haddon, John Maringa Githaka, et al.
BJUI Compass|April 7, 2023
PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancerVictoria K Woodcock, Ji-Li Chen, Karin Purshouse, et al.
Science (New York, N.Y.)|June 10, 1994
New phases of c60 synthesized at high pressureY Iwasa, T Arima, R M Fleming, et al.
Schizophrenia Bulletin|October 11, 2018
Genetic Variation in the Psychiatric Risk Gene CACNA1C Modulates Reversal Learning Across SpeciesLucy Sykes, Josephine Haddon, Thomas M Lancaster, et al.
Nature Communications|August 3, 2019
Cyfip1 haploinsufficient rats show white matter changes, myelin thinning, abnormal oligodendrocytes and behavioural inflexibilityAna I Silva, Josephine E Haddon, Yasir Ahmed Syed, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 14, 2014
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritisAndrew J Kinloch, Anthony Chang, Kichul Ko, et al.
Atherosclerosis|May 28, 2017
Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemiaMahtab Sharifi, Elizabeth Higginson, Sven Bos, et al.
Experimental Hematology|January 4, 2011
A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosisMichael R Hughes, Nicole Anderson, Steven Maltby, et al.
Pageof 51